Home / Stock ratings / Consumer Staples Stocks / CL

Stock rating

Colgate-Palmolive Company (CL) Stock Rating & Analysis

As of October 6, 2026, MELANY rates Colgate-Palmolive Company 59 out of 100 (Hold). Its highest factor score is catalyst setup at 78, and its lowest is valuation at 43.

MELANY ratingRated 2026-10-06

CL · composite score

59/100
Hold
···
Live price
Quality62
Momentum50
Risk-adjusted75
Source basis SEC filings and live market dataDated snapshot

Why CL scores 59/100

CL's 8 factor scores run from 43 to 78, and 5 of them sit above its composite of 59. Here is how CL breaks down.

Valuation43/100

Whether the price looks cheap or expensive against earnings, growth, and peers.

  • Forward P/E 21.3x, earnings growth accelerating
Business quality62/100

Margins, returns on capital, and balance-sheet strength.

  • Gross margin 60%
Price momentum50/100

Direction and relative strength of the recent share-price trend.

Earnings track record64/100

History of beating or missing estimates, and where estimates are heading.

  • Earnings in 24 days (strong beat history)
Analyst sentiment67/100

What Wall Street price targets and revisions are signalling.

Catalyst setup78/100

Near-term events that could move the stock.

  • Earnings in 24 days
Risk-adjusted profile75/100

Upside weighed against volatility and drawdown risk.

Macro fit50/100

How the current rate and market regime suits this kind of company.

How CL compares

As of October 7, 2026, Colgate-Palmolive Company is tied for 13th of 18 in Consumer Staples Stocks, where the average score is 60.

All stock rating pages.

Key risks for CL

  • High debt-to-equity ratio 13.9x, rate-sensitive balance sheet

Sector and theme context

Colgate-Palmolive Company sits in the Consumer staples (defensive) theme, which MELANY currently rates 3/100 for strength. Theme strength feeds CL's momentum and catalyst factors above.

Tracking CL

Colgate-Palmolive Company rates Hold right now, so MELANY is not flagging a fresh entry. Add CL to a watchlist in the app to follow its rating; an alert the moment it changes is part of Pro, free for 30 days.

How MELANY rates CL

MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Colgate-Palmolive Company's 59/100 reflects mature factor weighting for its profile.

Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.

Frequently asked questions about CL

Is Colgate-Palmolive Company (CL) a buy?

As of 2026-10-06, MELANY rated Colgate-Palmolive Company Hold with a composite score of 59/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.

What is Colgate-Palmolive Company's MELANY score?

Colgate-Palmolive Company (CL) has a MELANY composite score of 59/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.

How is the CL stock rating calculated?

MELANY scores CL from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.

Should I buy Colgate-Palmolive Company stock?

That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Colgate-Palmolive Company (CL) Hold with a composite of 59/100 as of 2026-10-06. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.

What is the CL stock price forecast?

MELANY does not publish price targets or forecasts for CL. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 59/100 across eight factors for Colgate-Palmolive Company, and re-scores automatically as new price, earnings, and fundamental data arrive.

Is CL stock overvalued or undervalued?

MELANY's valuation factor currently reads 43/100 for Colgate-Palmolive Company, where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives CL's read.

What price should I buy CL at?

MELANY is not flagging a fresh entry for CL at its current Hold rating, so there is no entry zone to publish right now. Add CL to a watchlist in the app to follow it; an alert the moment the rating changes is part of Pro, free for 30 days.

What are the risks of buying CL stock?

The top risks MELANY currently flags for Colgate-Palmolive Company: High debt-to-equity ratio 13.9x, rate-sensitive balance sheet. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.

Is Colgate-Palmolive Company a good long-term investment?

For long-term durability the two factors that matter most are business quality, which MELANY scores 62/100 for Colgate-Palmolive Company, and earnings track record, at 64/100. The 59/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.

Will CL stock go up?

Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 50/100 for CL right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.

How current is this CL rating?

The rating on this page is a snapshot of MELANY's read as of 2026-10-06. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores CL continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).

How this rating works

Market Eyes Live

Every rating graded in public, CL included

MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.

Get the free iOS app Create a free account on the web Free account, no card. Pro: 30 days free, then $9.99 a month.